Impact of clinical and molecular predictors of benefit from erlotinib in advanced non-small cell lung cancer on cost-effectiveness Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bradbury, PA
  • Tu, D
  • Seymour, L
  • Ng, R
  • Zhu, L
  • Isogai, PK
  • Mittmann, N
  • Evans, William
  • Shepherd, FA
  • Leighl, NB

publication date

  • May 20, 2008